Acute hepatitis C
ICD-10 B17.1 · ICD-11 1E50.2

Treatment of Acute Hepatitis C at Initial Diagnosis with Confirmed Viremia

When acute hepatitis C is diagnosed and HCV RNA is quantifiable, current guidance calls for prompt antiviral treatment — not a period of watchful waiting. The clinical protocol covers regimen selection, genotyping decisions, and additional management steps relevant to this presentation.

Clinical scenario: Patient has an initial diagnosis of acute HCV infection with confirmed viremia on quantifiable RNA testing. Management decisions include whether genotyping is available, whether exposure to more than one genotype is a concern, and whether substance use was involved in acquisition. Counseling on hepatotoxic substances is part of the initial management plan.
Treatment approach — partial overview

The recommended strategy involves initiating direct-acting antiviral therapy at the time of initial diagnosis, without waiting for spontaneous resolution. When genotyping results are unavailable or multi-genotype exposure cannot be excluded, a pangenotypic regimen is the preferred choice. The complete protocol specifies regimen options, substance-use referral pathways, and additional counseling guidance beyond what is shown here.

Instant Access to Structured Evidence-Based Regimens

References

View source ↗